Optimind Pharma (XCNQ:OMND) ROCE % : 0.00% (As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Optimind Pharma's annualized ROCE % for the quarter that ended in Nov. 2024 was 0.00%.

Optimind Pharma ROCE % Historical Data

The historical data trend for Optimind Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma ROCE % Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Feb24

ROCE %

-155.27

-438.33

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
ROCE %	Get a 7-Day Free Trial							-151.92	-	-	-	-

Optimind Pharma ROCE % Calculation

Optimind Pharma's annualized ROCE % for the fiscal year that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Feb. 2024 )		(A: Feb. 2023 )		(A: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Feb. 2024 )		(A: Feb. 2023 )		(A: Feb. 2024 )
	=	-1.315	/	( ( (1.354 - 0.625)	+	(0.238 - 0.367) )	/ 2 )
	=	-1.315	/	( (0.729	+	-0.129)	/ 2 )
	=	-1.315	/	0.3
	=	-438.33 %

Optimind Pharma's ROCE % of for the quarter that ended in Nov. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Nov. 2024 )		(Q: Aug. 2024 )		(Q: Nov. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Nov. 2024 )		(Q: Aug. 2024 )		(Q: Nov. 2024 )
	=	-0.036	/	( ( (0.219 - 0.258)	+	(0.213 - 0.261) )	/ 2 )
	=	-0.036	/	( ( -0.039	+	-0.048 )	/ 2 )
	=	-0.036	/	-0.0435
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Nov. 2024) EBIT data.

Optimind Pharma (XCNQ:OMND) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Optimind Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines